Improving Time to Market: Removing Bottlenecks to Market Access & Improving Options | Session Recording

Join leading experts from Bayer, Health Canada, Arthritis Society, and Knight Therapeutics as they dive deep into the challenges of bringing innovative treatments to Canadian patients. Key highlights include: insights from regulatory, industry, and patient perspectives, challenges in Canada’s drug approval process, innovative approaches to streamline market access and more.

In this panel discussion, industry leaders explore:

• Current bottlenecks in drug approval and reimbursement
• Strategies to accelerate patient access to new treatments
• Collaborative approaches between government, industry & patient groups
• Future solutions for a more efficient healthcare system

Featuring:

• Jody Engel (Knight Therapeutics)
• Brendon Levac (Bayer Healthcare)
• Dr. Alysha Croker (Health Canada)
• Kelly Gorman (Arthritis Society Canada)